2010

  • Akbaraly TN, Singh-Manoux A, Tabak AG, Jokela M, Virtanen M, Ferrie JE, Marmot MG, Shipley MJ, Kivimaki M. Overall diet history and reversibility of the metabolic syndrome over 5 years: the Whitehall II prospective cohort study. Diabetes Care. 2010 Nov;33(11):2339-41.
  • Akbaraly TN, Kivimaki M, Shipley MJ, Tabak AG, Jokela M, Virtanen M, Marmot MG, Ferrie JE, Singh-Manoux A. Metabolic syndrome over 10 years and cognitive functioning in late midlife: the Whitehall II study. Diabetes Care. 2010 Jan;33(1):84-9.
  • Britton A., Shipley M. Bored to death. Int J Epidemiology 2010 ;39:370-1
  • Britton A, Marmot M, Shipley M. How does variability in alcohol consumption over time affect the relationship with mortality and coronary heart disease? Addiction. 2010;105:639-45
  • Britton A, Marmot M, Shipley M. Authors’ response to commentary. Addiction 2010;105:647-8
  • Brunner EJ, Shipley MJ, Marmot MG, Kivimäki M, Witte DR. Do the Joint British Society (JBS2) guidelines on prevention of cardiovascular disease with respect to plasma glucose improve risk stratification in the general population? Prospective cohort study. Diabetic Medicine 2010;27,550-555.
  • Kivimaki M. Height loss and future coronary heart disease in London: the Whitehall II study. J Epidemiol Community Health. 2010 Aug 30.
  • Batty D, Shipley M, Kivimaki M, Marmot MG, Davey Smith G. Walking pace, leisure time physical activity, and resting heart rate in relation to disease-specific mortality in London: 40 years follow-up of the original Whitehall study. An update of our work with professor Jerry N. Morris (1910-2009). Ann Epidemiol. 2010 Sep;20(9):661-9.
  • Carstensen M, Herder C, Brunner EJ, Strassburger K, Tabak AG, Roden M, Witte DR. Macrophage inhibitory cytokine-1 is increased in individuals before type 2 diabetes diagnosis but is not an independent predictor of type 2 diabetes: the Whitehall II study. Eur J Endocrinol. 2010 May;162(5):913-7.
  • Carstensen M, Herder C, Kivimäki M, Jokela M, Roden M, Shipley MJ, Witte DR, Brunner EJ, Tabák AG. Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study. Diabetes. 2010 May;59(5):1222-7.
  • Casas JP, [...], Kumari M, Brunner EJ, Kivimaki M, Marmot MG, et al. PLA2G7 Genotype, Lipoprotein-Associated Phospholipase A2 Activity, and Coronary Heart Disease Risk in 10 494 Cases and 15 624 Controls of European Ancestry. Circulation. 2010 Jun 1;121(21):2284-93.
  • Chandola T, Ferrie JE, Perski A, Akbaraly T, Marmot MG. The effect of short sleep duration on coronary heart disease risk is greatest among those with sleep disturbance: a prospective study from the Whitehall II cohort. Sleep. 2010 Jun 1;33(6):739-44.
  • Chandola T, Heraclides A, Kumari M. Psychophysiological biomarkers of workplace stressors. Neurosci Biobehav Rev. 2010 Sep;35(1):51-7.
  • Christensen D.L., Witte D.R., Kaduka L., Jørgensen M., Borch-Johnsen K., Mohan V., Shaw D., Tabák A.G., Vistisen D.: Moving to an HbA1c based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabetes Care 32 in press
  • Dahm CC, Keogh RH, Spencer EA, Greenwood DC, Key TJ, Fentiman IS Shipley MJ, Brunner EJ, Cade JE, Burley VJ, Mishra G, Stephen AM, Kuh D, White IR, Luben R, Lentjes MAH, Khaw KT, Rodwell (Bingham) SA.Dietary fiber with colorectal cancer risk: a nested case control study using food diaries. J Natl Cancer Inst 2010:102:1-13
  • Dupuis, J., Langenberg, C., Prokopenko, I., et al for the MAGIC investigators (>100 authors). Novel genetic loci implicated in fasting glucose homeostasis 3 and their impact on type 2 diabetes risk. Nature Genetics 2010;42, 142-148.
  • Elovainio M, Singh-Manoux A, Ferrie JE, Shipley M, Gimeno D, De Vogli R, Vahtera J, Virtanen M, Jokela M, Marmot MG, Kivimäki M. Organisational justice and cognitive function in middle-aged employees: the Whitehall II study. J Epidemiol Community Health. 2010 Nov 17.
  • Elovainio M, Ferrie JE, Singh-Manoux A, Gimeno D, De Vogli R, Shipley M, Vahtera J, Brunner E, Marmot MG, Kivimäki M. Organisational justice and markers of inflammation: the Whitehall II study. Occup Environ Med. 2010 Feb;67(2):78-83.
  • Ferrie JE, Kivimäki M, Shipley M. Sleep and Death. Chapter 4. Sleep, Health and Society: From Aetiology to Public Health. Ed. Cappuccio FP, Miller M and Lockley S. Oxford University Press September 2010
  • Fransson EI, Batty GD, Tabák AG, Brunner EJ, Kumari M, Shipley MJ, Singh-Manoux A, Kivimäki M. Association between change in body composition and change in inflammatory markers: an 11-year follow-up in the Whitehall II Study. J Clin Endocrinol Metab. 2010 Dec;95(12):5370-4.
  • Gimeno D, Tabák AG, Ferrie JE, Shipley MJ, De Vogli R, Elovainio M, Vahtera J, Marmot MG, Kivimäki M. Justice at work and metabolic syndrome: the Whitehall II study. Occup Environ Med. 2010 Apr;67(4):256-62.
  • Hamer M, Kivimaki M, Lahiri A, Yerramasu A, Deanfield JE, Marmot MG, Steptoe A. Walking speed and subclinical atherosclerosis in healthy older adults: the Whitehall II study. Heart. 2010 Mar;96(5):380-4.
  • Hamer, M., Kivimäki, M., Lahiri, A., Marmot, M. G., Steptoe, A. Persistent cognitive depressive symptoms are associated with coronary artery calcification. Atherosclerosis, 2010;210, 209-213.
  • Heraclides A, Brunner E. Social mobility and social accumulation across the life course in relation to adult overweight and obesity: the Whitehall II study. J Epidemiol Community Health. 2010 Aug;64(8):714-9.
  • Hingorani AD, Shah T, Kumari M, Sofat R, Smeeth L. Translating genomics into improved healthcare.BMJ. 2010 Nov 5;341.
  • Hintsa T, Shipley MJ, Gimeno D, Elovainio M, Chandola T, Jokela M, Keltikangas-Järvinen L, Vahtera J, Marmot MG, Kivimäki M. Do pre-employment influences explain the association between psychosocial factors at work and coronary heart disease? The Whitehall II study. Occup Environ Med. 2010 May;67(5):330-4.
  • Jokela M, Singh-Manoux A, Ferrie JE, Gimeno D, Akbaraly TN, Shipley MJ, Head J, Elovainio M, Marmot MG, Kivimäki M. The association of cognitive performance with mental health and physical functioning strengthens with age: the Whitehall II cohort study. Psychol Med. 2010 May;40(5):837-45.
  • Jokela M, Singh-Manoux A, Shipley MJ, Ferrie JE, Gimeno D, Akbaraly TN, Head J, Elovainio M, Marmot MG, Kivimäki M. Natural course of recurrent psychological distress in adulthood. J of Affect Disord 2010.
  • Jokela M, Ferrie JE, Gimeno D, Chandola T, Shipley MJ, Head J, Vahtera J, Westerlund H, Marmot MG, Kivimäki M. From midlife to early old age: health trajectories associated with retirement. Epidemiology 2010, 21, 284-290
  • Ken-Dror, G., Drenos, F., Humphries, S. E., Talmud, P. J., Hingorani, A. D., Kivimäki, M., Kumari, M., Bauer, K. A., Morrissey, J. H., Ireland, H. A. Haplotype and genotype effects of the F7 gene on circulating factor VII, coagulation activation markers and incident coronary heart disease in UK men. Journal of Thrombosis and Haemostasis, 2010; 8, 2394-2403.
  • Kivimäki M, Tabak A, Batty GD, Ferrie JE, Nabi H, Marmot MG, Witte DR, Singh-Manoux A, Shipley MJ. Incremental predictive value of using past blood pressure measurements in the Framingham hypertension risk equation: the Whitehall II study. Hypertension 2010 Apr;55(4):1058-62
  • Kivimäki M, Singh-Manoux A, Batty GD, Virtanen M, Ferrie JE, Vahtera J. Psychosocial Factors at Work: The Epidemiological Perspective. Chapter 11, Stress and Cardiovascular Disease. Ed. Hjemdahl P, Rosengren A, Steptoe A. Springer July 2010.
  • Kumari M, Badrick E, Sacker A, Kirschbaum C, Marmot M, Chandola T. Identifying patterns in cortisol secretion in an older population. Findings from the Whitehall II study. Psychoneuroendocrinology. 2010 Aug;35(7):1091-9.
  • Kumari M, Chandola T, Brunner E, Kivimaki M. A nonlinear relationship of generalized and central obesity with diurnal cortisol secretion in the Whitehall II study. J Clin Endocrinol Metab. 2010 Sep;95(9):4415-23.
  • Kumari M, Badrick E, Chandola T, Adler NE, Epel E, Seeman T, Kirschbaum C, Marmot MG. Measures of social position and cortisol secretion in an aging population: findings from the Whitehall II study. Psychosom Med. 2010 Jan;72(1):27-34.
  • Laaksonen E, Lallukka T, Lahelma E, Ferrie JE, Rahkonen O, Head J, Marmot M, Martikainen P. Economic difficulties and physical functioning among Finnish and British employees: the contribution of social and behavioural factors. Eur.J.Pub.Health 2010 Jul 8.
  • Lahelma E, Lallukka T, Laaksonen M, Martikainen P, Rahkonen O, Chandola T, Head J, Marmot M, Kagamimori S, Tatsuse T, Sekine M. Social class differences in health behaviours among employees from Britain, Finland and Japan: The influence of psychosocial factors. Health Place 2010 Jan;16(1):61-70.
  • Miller MA, Kandala NB, Kumari M, Marmot MG, Cappuccio FP. Relationships between sleep duration and von Willebrand factor, factor VII, and fibrinogen: Whitehall II study. Arterioscler Thromb Vasc Biol. 2010 Oct;30(10):2032-8.
  • Nabi H, Shipley MJ, Vahtera J, Hall M, Korkeila J, Marmot MG, Kivimäki M, Singh-Manoux A. Effects of depressive symptoms and coronary heart disease and their interactive associations on mortality in middle-aged adults: the Whitehall II cohort study. Heart. 2010 Oct;96(20):1645-50.
  • Nabi H, Singh-Manoux A, Ferrie JE, Marmot MG, Melchior M, Kivimäki M. Hostility and depressive mood: results from the Whitehall II prospective cohort study. Psychol Med. 2010 Mar;40(3):405-13.
  • Park JY, Dahm CC, Keogh RH, Mitrou PN, Cairns BJ, Greenwood DC, Spencer EA, Fentiman IS, Shipley MJ, Brunner EJ, Cade JE, Burley VJ, Mishra GD, Kuh D, Stephen AM, White IR, Luben RN, Mulligan AA, Khaw K-T, Rodwell SA. Alcohol intake and risk of colorectal cancer: results from the UK Dietary Cohort Consortium. Brit J Cancer 2010;103: 747-756.
  • Sabia S, Shipley M, Elbaz A, Marmot M, Kivimaki M, Kauffmann F, Singh-Manoux A. Why does lung function predict mortality? Results from the Whitehall II Cohort Study. Am J Epidemiol. 2010 Dec 15;172(12):1415-23.
  • Sabia S, Guéguen A, Marmot MG, Shipley MJ, Ankri J, Singh-Manoux A. Does cognition predict mortality in midlife? Results from the Whitehall II cohort study. Neurobiol Aging. 2010 Apr;31(4):688-95. Epub 2008 Jun 9.
  • Sabia S, Kivimaki M, Kumari M, Shipley MJ, Singh-Manoux A. Effect of Apolipoprotein E epsilon4 on the association between health behaviors and cognitive function in late midlife. Mol Neurodegener. 2010 Jun 1;5(1):23.
  • Salavecz G, Chandola T, Pikhart H, Dragano N, Siegrist J, Jöckel KH, Erbel R, Pajak A, Malyutina S, Kubinova R, Marmot M, Bobak M, Kopp M. Work stress and health in Western European and post-communist countries: an East-West comparison study. J Epidemiol Community Health. 2010 Jan;64(1):57-62.
  • Saxena, R., […..],Kivimaki M, […..], Kumari M, […..], Marmot M, et al., Genetic variation in gastric inhibitory polypeptide receptor (GIPR) impacts the glucose and insulin responses to an oral glucose challenge. Nature Genetics, 2010; 42, 142-148.
  • Singh-Manoux A, Akbaraly TN, Marmot M, Melchior M, Ankri J, Sabia S, Ferrie JE. Persistent depressive symptoms and cognitive function in late midlife: The Whitehall II study. J Clin Psychiatry 2010; 71: 1379-85. 
  • Singh-Manoux A, Kivimäki M. The importance of cognitive ageing for understanding dementia. Age 2010; 32: 509-512.
  • Singh-Manoux A, Stringhini S. Socioeconomic position and mortality-Reply. JAMA 2010; 204: 271.
  • Singh-Manoux A. Commentary: Is it time to redefine Cognitive Epidemiology? Int J Epidemiol 2010; 39:1369-71
  • Smart-Halajko, M. C., Robciuc, M. R., Cooper, J. A., Jauhiainen, M., Kumari, M., Kivimäki, M., Khaw, K-T., Boekholdt, M., Wareham, N. J., Gaunt, T. R., Day, I. N. on behalf of BWHHS, Braund, P. S., Nelson, C. P., Hall, A. S., Samani, N. J. on behalf of the BHF-FHS, Humphries, S. E., Ehnholm, C., Talmud, P. J. (2010). The relationship between plasma angiopoietinlike protein l4 levels, angioloietinlike protein 4 genotype and coronary heart disease risk. Arteriosclerosis, Thrombosis and Vascular Biology, 30, 2217-2282.
  • Sofat, R., Casas, J. P., Kumari, M., Talmud, P. J., Ireland, H., Kivimäki, M., Marmot, M., Hughes, A. D., Thom, S., Ebrahim, S., Whittaker, J. C., Smeeth, L., Lawlor, D. A., Humphries, S. E., Hingorani, A. D. (2010). Genetic variation in complement factor H and risk of coronary heart disease: Eight new studies and a meta-analysis of around 48,000 individuals. Atherosclerosis, 121, 52-62.
  • Sofat R, Hingorani AD, Smeeth L, Humphries SE, [...], Kumari M, Kivimaki M, Marmot M, et al. Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms. Circulation. 2010 Jan 5;121(1):52-62.
  • Steptoe A, Hamer M, O'Donnell K, Venuraju S, Marmot MG, Lahiri A. Socioeconomic status and subclinical coronary disease in the Whitehall II epidemiological study. PLoS One. 2010 Jan 25;5(1):e8874.
  • Stringhini S, Dugravot A, Kivimaki M, Shipley M, Zins M, Goldberg M, Ferrie JE, Singh-Manoux A. Do different measures of early life socioeconomic circumstances predict adult mortality? Evidence from the British Whitehall II and French GAZEL studies. J Epidemiol Community Health. 2010 Jul 30.
  • Stringhini S, Sabia S, Shipley M, Brunner E, Nabi H, Kivimaki M, Singh-Manoux A. Contribution of health behaviours to socioeconomic differences in mortality in the Whitehall II study. JAMA 2010;303(12):1159-1166.
  • Tabák AG, Kivimäki M, Brunner EJ, Lowe GD, Jokela M, Akbaraly TN, Singh-Manoux A, Ferrie JE, Witte DR. Changes in C-reactive protein levels before type 2 diabetes and cardiovascular death: the Whitehall II study. Eur J Endocrinol. 2010 Jul;163(1):89-95.
  • Talmud PJ, Hingorani AD, Cooper JA, Marmot MG, Brunner EJ, Kumari M, Kivimäkin M, Humphries SE. Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ. 2010 Jan 14;340:b4838.
  • Virtanen M, Ferrie JE, Singh-Manoux A, Shipley MJ, Vahtera J, Marmot MG, Kivimäki M. Overtime work and incident coronary heart disease: the Whitehall II prospective cohort study. Eur Heart J. 2010 Jul;31(14):1737-44. Epub 2010 May 11.
  • Virtanen M, Kivimäki M, Singh-Manoux A, Gimeno D, Shipley MJ, Vahtera J, Akbaraly TN, Marmot MG, Ferrie JE. Work disability following major organisational change: the Whitehall II study. J Epidemiol Community Health. 2010 May;64(5):461-4.
  • Witte DR, Shipley MJ, Marmot MG, Brunner EJ. Performance of existing risk scores in screening for undiagnosed diabetes: An external validation study. Diabetic Medicine, 2010;27:46-53

Consortium Papers

  • CRP CHD genetics collaboration. Bayesian methods for meta-analysis of causal relationships estimated using genetic instrumental variables. Statistics in Medicine (in press)
  • Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration, Sarwar N, Sandhu MS, Ricketts SL, Butterworth AS, Di Angelantonio E, Boekholdt SM, Ouwehand W, Watkins H, Samani NJ, Saleheen D, Lawlor D, Reilly MP, Hingorani AD, Talmud PJ, Danesh J. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet. 2010 May 8;375(9726):1634-9.

Page last modified on 13 jun 12 11:23